Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient
NCT06090825 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2023-10-19
Summary
It is a real-world observational cross-sectional follow-up study on clinical palliative care for pancreatic cancer patients in China. It is evaluated by an online questionnaire sent to the doctors from the General Surgery Department in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland.
Conditions
Interventions
- OTHER
-
Observational study
Observational study
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Principal Investigators
-
Qiaofei Liu · Department of General Surgery, Peking Union Medical College Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-09-01
- Completion
- 2025-09-01
Countries
- China
Study Locations
More Related Trials
-
Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis
NCT04677192 ·Status: UNKNOWN ·Phase: PHASE2
-
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
NCT06208436 ·Status: RECRUITING
-
Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
NCT06307080 ·Status: RECRUITING ·Phase: NA
-
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.
NCT04835064 ·Status: UNKNOWN ·Phase: PHASE3
-
Multimodal Therapy Impact on Pancreatic Cancer Survival
NCT06938906 ·Status: ACTIVE_NOT_RECRUITING
-
mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer
NCT02028806 ·Status: COMPLETED ·Phase: PHASE2
-
Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
NCT00003029 ·Status: COMPLETED ·Phase: PHASE3
-
Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer Patients
NCT06310902 ·Status: RECRUITING
-
Early Palliative Care for Patients With Advanced Pancreatic Cancer.
NCT04632303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer
NCT05201729 ·Status: UNKNOWN
-
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
NCT02506842 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain
NCT02510066 ·Status: UNKNOWN ·Phase: PHASE3
-
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
NCT00805688 ·Status: COMPLETED
-
Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients
NCT06736678 ·Status: RECRUITING ·Phase: NA
-
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
NCT03398291 ·Status: UNKNOWN ·Phase: PHASE3
-
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
NCT01760694 ·Status: TERMINATED ·Phase: NA
-
Translational Research on Locally Advanced Pancreatic Adenocarcinoma
NCT03009253 ·Status: UNKNOWN ·Phase: NA
-
Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
NCT00112697 ·Status: COMPLETED ·Phase: PHASE2
-
Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer
NCT05729737 ·Status: RECRUITING
-
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
NCT06478225 ·Status: RECRUITING ·Phase: NA
-
mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients
NCT04084496 ·Status: RECRUITING ·Phase: PHASE2
-
Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer
NCT03432624 ·Status: UNKNOWN
-
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer
NCT03850769 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient
NCT02338752 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diet and Exercise After Pancreatic Cancer
NCT03187028 ·Status: COMPLETED ·Phase: NA